Skip to content

PREDICTING THE WIDE-RANGING EFFECTS OF ENHANCING DOPAMINE ON COGNITION

PREDICTING THE WIDE-RANGING EFFECTS OF ENHANCING DOPAMINE ON COGNITION - DOPAMINE AND COGNITION

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38150
Enrollment
100
Registered
2014-01-30
Start date
2014-04-14
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

distractability lack of motivation

Interventions

None listed

Sponsors

Radboud Universiteit Nijmegen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Healthy volunteers between 18 and 45 years of age

Exclusion criteria

Exclusion criteria: Neuropsychiatric disorders; history of drug abuse; heart problems (see section 3.3 in research protocol (C1) for full list of exclusion criteria)

Design outcomes

Primary

MeasureTime frame
The current study will collect the following primary study parameters Baseline measures: Barratt Simplified Measure of Social Status (Average score) Multidimensional Scale of Perceived Social Support (Average score) Dominance scale (Average score) The Beck Depression Inventory (Average score) The Barratt Impulsiveness Scale (Average score) The BIS/BAS (Behavioural Inhibition Scale/Behavioural Activation (BIS/BAS) Scale (Average score) The Daneman and Carpenter listening span test (Average score) Outcome measures: Social Learning (Beta value for personal learning) Social Learning (Win-stay, lose-shift behaviour) Social Learning (Perseveration) Working memory (Accuracy and reaction time) Motivation x activation reinforcement learning task (Pavlovian bias) Probabilistic reversal learning (Lose-switch, win-stay behaviour) Probabilistic reversal learning (Perseveration) Pavlovian to Instrumental Transfer (Vigour changes upon Pavlovian stimuli) Demand selection task task (Bias towards easy/difficult condition)

Secondary

MeasureTime frame
Secondary measures will also be collected for each task (see section 6.1.2 of the research protocol (C1) for further details)

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)